Wearable Artificial Kidney Market Size, Share & Trends Analysis Report By Patient Type (End-stage Renal Disease, Acute Renal Disease), By Material (Hemodialysis), By Application, By Region, And Segment Forecasts, 2025 - 2030

Wearable Artificial Kidney Market Trends

The global wearable artificial kidney market size was valued at USD 575.5 million in 2024 and is anticipated to grow at a CAGR of 6.9% from 2025 to 2030. The demand for wearable artificial kidneys is expected to increase due to the incidence of chronic kidney diseases, such as end-stage renal disease and acute renal disease. The dialysis machines offer a promising solution by providing continuous blood filtration, allowing patients greater mobility and flexibility. In addition, the device can also provide reliance on financial burden on healthcare systems. Moreover, technological advancements such as artificial intelligence and machine learning in wearable devices are enhancing feasibility and effectiveness, leading to increased investments in research and development.

Technological advancements in biotechnology and miniaturization techniques are leading to certain developments in portable devices that allow for continuous blood purification outside clinical settings. This allows patients to wear the device securely, enabling them to maintain their daily activities without being tied to traditional dialysis machines. In addition, the demand for home hemodialysis is expected to increase as patients consider it a viable and considerable treatment at home.

According to a press release published by Texas A&M University Veterinary Medicine & Biomedical Sciences in May 2024, a technology called the Ark creates a permanent port in the patient's arm. This port allows access to a high-flow vein that can handle repeated punctures with large dialysis needles. The technology is also expected to be approved by the U.S. Food and Drug Administration.

Initiatives such as KidneyX, a partnership between the U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology, provide funding opportunities for innovations in kidney care technologies, including wearable artificial kidneys. This initiative also increases research and development, ensuring safety standards are maintained while fostering innovation in kidney disease treatment options.

Patient Type Insights

The acute renal disease dominated the market for the largest revenue share of 67.0% in 2024 and is expected to grow at the fastest CAGR of 7.1% over the forecast period. The growth in demand for wearable artificial kidneys is attributed to the increasing rates of diabetes and hypertension. Wearable artificial kidneys are worn for daily use, which is beneficial for individuals suffering from acute renal disease. In addition, it provides clearance and ultrafiltration, which is crucial for patients prone to this type of disease.

The demand in this segment is expected to grow with continuous treatment capability and improved patient mobility. The portable device is designed to provide continuous blood purification, crucial for managing the disease effectively. Unlike traditional dialysis, which operates in sessions lasting several hours, wearable artificial kidneys can operate constantly, which allows better fluid and electrolyte management. Furthermore, this constant operation helps stabilize patients with acute conditions and prevent any risks to kidney function.

Material Insights

The peritoneal dialysis accounted for the largest revenue share of 55.6% in 2024 and is expected to grow at the fastest CAGR of 7.0% over the forecast period. The demand for peritoneal dialysis has increased due to the demand for home-based therapy and patient-centric approach. According to The Ohio State University Wexner Medical Center, 8 to 10.0% of patients worldwide utilize home-based therapy. In addition, this modality allows patients to manage their treatment, enhancing quality of life and reducing the burden on healthcare facilities. Furthermore, peritoneal dialysis has become convenient for patients who avoid frequent visits to dialysis centers.

The demand for this segment is expected to increase with campaign awareness and regulatory support. According to a press release published by Thai PBS World in November 2024, Thailand imposed a PD-First Policy, in which new kidney-failure patients are expected to receive peritoneal dialysis to reduce the financial burden and cost of treatment. In addition, the National Security Health Office (NSHO) is expected to provide peritoneal dialysis treatment to its patients after finding out that hemodialysis offers fewer health benefits. Therefore, the demand for peritoneal dialysis treatment is expected to rise.

Application Insights

Hospitals, under the application segment, dominated the market with the largest revenue share of 37.0% in 2024, attributed to the growth of continuous treatment capability and regulatory approvals. Advancements in wearable artificial kidney technology, such as miniaturization and improved biocompatibility, have made these devices more practical for clinical use. Hospitals are equipped to implement these innovations quickly, utilizing their existing infrastructure to integrate new technologies into patient care protocols. For instance, devices that allow for continuous blood purification while enabling patient mobility can significantly enhance treatment options available in hospital settings.

Dialysis centers are expected to grow at the fastest CAGR of 7.0% over the forecast period, contributing to their cost-effectiveness and awareness. Wearable artificial kidneys can potentially reduce the dependency on in-center dialysis, leading to substantial cost savings for both patients. This initiative is expected to encourage dialysis centers to incorporate these innovative solutions into their service offerings. Increasing awareness about kidney diseases and the benefits of wearable artificial kidneys is leading to greater acceptance among patients and healthcare providers. Dialysis centers can leverage educational initiatives to inform patients about the advantages of these technologies, further driving their adoption.

Regional Insights

The wearable artificial kidney market in North America dominated the market with the largest revenue share of 36.3% in 2024 due to its growth in healthcare infrastructure and technological advancements. The region is advanced in developing advanced wearable artificial kidney technologies. These innovations enhance the functionality and usability of devices, making them more appealing to patients and healthcare providers. Companies such as Vivance are at the forefront of contributing to the region's dominance in the market.

U.S. Wearable Artificial Kidney Market Trends

U.S. dominated the North American region with the largest revenue share of 83.8% in 2024. The incidence of chronic kidney diseases, particularly end-stage renal diseases, is increasing. The growing patient population creates a high demand for innovative treatment options, such as wearable artificial kidney, which provides continuous dialysis outside traditional clinical settings. Initiatives such as research and development are conducted to reduce chronic diseases, backed by technological advancements.

Mexico Wearable Artificial Kidney Market Trends

The wearable artificial kidney market in Mexico is expected to register the fastest CAGR of 9.2% over the forecast period. Kidney disease is a significant public health issue in Mexico, largely driven by the high incidence of diabetes and hypertension, which are the leading causes of chronic kidney disease (CKD). The country has one of the highest rates of diabetes in the world, and this chronic condition often leads to kidney complications. This results in a growing patient population requiring renal replacement therapies, creating a demand for innovative solutions such as the WAK. In addition, in Mexico, access to dialysis centers is not uniform, with rural and remote areas facing considerable challenges in obtaining regular treatment. The WAK offers a wearable, user-friendly solution that allows patients to perform dialysis while maintaining their independence and mobility.

Asia Pacific Wearable Artificial Kidney Market Trends

The wearable artificial kidney market in the Asia Pacific is expected to grow at the fastest CAGR of 7.8% over the forecast period. The region has a high prevalence of chronic kidney diseases, aggravated by diabetes and hypertension, leading to a growing need for dialysis. Traditional dialysis treatments often face logistical barriers, especially in rural areas, and WAKs offer a portable, continuous solution that allows patients to maintain a more flexible lifestyle. In addition, advancements in medical technology, improved healthcare infrastructure, and rising awareness of such innovations are contributing to the increased adoption of WAKs in this region.

China Wearable Artificial Kidney Market Trends

Within the Asia Pacific region, China dominated the market with the largest revenue share of 23.0% in 2024. The country has a rapidly aging population and a high prevalence of chronic diseases such as diabetes and hypertension, which are leading causes of kidney failure. WAKs offer a portable and continuous solution, allowing patients to receive treatment outside conventional clinics. Moreover, China’s significant investments in healthcare technology and its ongoing healthcare reforms are helping to drive the adoption of innovative solutions such as WAKs. In addition, WAKs offer patients greater flexibility and improve their quality of life by eliminating the need for frequent hospital visits. These benefits and a growing awareness of wearable medical devices have created a demand for this cutting-edge solution in China’s healthcare market.

Key Wearable Artificial Kidney Company Insights

Some key players in the market are Vivance. (AWAK Technologies); VICTOR GURA, M.D.; KidneyX; NephriaBio; Nextkidney. These companies employ various strategies to gain a competitive edge, such as launching new products to cater to diverse patient needs, focusing on personalized medicine to enhance treatment efficacy, and leveraging emerging markets to tap into increasing awareness about botanicals and acupuncture. Furthermore, these businesses engage in collaborative research initiatives with healthcare organizations to drive innovation while integrating digital health solutions for enhanced patient access and adherence.

• Vivance (AWAK Technologies) is a medical technology company that focuses on enhancing kidney care through innovative solutions. The company has made significant progress in the wearable artificial kidney market with its product, the Viva Kompact.The trial evaluated the device's performance and safety when used by patients in their home environment.

• KidneyX is a public-private partnership initiated by the U.S. Department of Health and Human Services (HHS). The company aims to accelerate innovation in kidney care, particularly by developing new technologies, including wearable artificial kidneys. In addition, it provides funding and support for kidney treatment and renal replacement therapies.

Recent Developments

• In October 2024, AWAK Technologies rebranded its identity into Vivance., which is aimed at improving kidney health. Vivance's flagship product, the Viva Kompact, is a wearable peritoneal dialysis device designed for home use, allowing patients greater flexibility and independence in managing their treatment. The new identity signifies a broader vision for the company as it seeks to expand its product offerings and improve the quality of life for individuals with kidney disease.

Wearable Artificial Kidney Market Report Scope

Global Wearable Artificial Kidney Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and analyzes the latest industry trends in each sub-segment from 2018 to 2030. For this study, Grand View Research has segmented the global wearable artificial kidney market report based on patient type, material, application, and region.

• Patient Type Outlook (Revenue, USD Million, 2018 - 2030)

  • End-Stage Renal Disease

  • Acute Renal Disease

• Material Outlook (Revenue, USD Million, 2018 - 2030)

  • Hemodialysis

  • Peritoneal Dialysis

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Ambulatory Surgical Centers

  • Dialysis Centers

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Russia

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait